ILIAC ARTERY OCCLUSION side effect
What is ILIAC ARTERY OCCLUSION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
ILIAC ARTERY OCCLUSION and Recently Reported Side Effects
ILIAC ARTERY OCCLUSION and 15 most Active Side Effect polls
ILIAC ARTERY OCCLUSION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with ILIAC ARTERY OCCLUSION
CAPECITABINE CILOSTAZOL CYCLOPHOSPHAMIDE DOXIL FABRAZYME FOSAMAX GEMZAR ORTHOOrtho Side Effects Report #5412512-2
Health Professional from UNITED STATES reported ORTHO EVRA problem on Mar 13, 2007. Female patient, 24 years of age, weighting 133.2 lb, was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: iliac artery occlusion, myocardial infarction, . ORTHO EVRA dosage: unknown. During the same period patient was treated with NEXIUM. Patient was hospitalized. Patient recovered.
Ortho Side Effects Report #5412512-2
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, 24 years of age, weighting 133.2 lb, was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: iliac artery occlusion, myocardial infarction, . ORTHO EVRA dosage: unknown. During the same period patient was treated with NEXIUM. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5319998-2
Physician from UNITED STATES reported FABRAZYME problem on Apr 24, 2007. Female patient, 58 years of age, weighting 153.2 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: iliac artery occlusion, . FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Cyclophosphamide Side Effects Report #5325014-9
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Male patient, weighting 154.3 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: iliac artery occlusion, pelvic venous thrombosis, . CYCLOPHOSPHAMIDE dosage: 2280 MG. During the same period patient was treated with DAUNORUBICIN, DEXAMETHASONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5297272-0
Physician from BELGIUM reported GEMZAR problem on Apr 11, 2007. Male patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: iliac artery occlusion, malignant neoplasm progression, . GEMZAR dosage: 1200 MG/M2, UNK. During the same period patient was treated with CISPLATIN. Patient was hospitalized and became disabled. Patient died.
Ortho Side Effects Report #5275956-8
ORTHO EVRA problem was reported by a Health Professional from UNITED STATES on Sept 29, 2006. Female patient, 24 years of age, weighting 133.2 lb, was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: iliac artery occlusion, myocardial infarction, . ORTHO EVRA dosage: unknown. During the same period patient was treated with NEXIUM. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5585986-4
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Dec 26, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: arterial disorder, iliac artery occlusion, myocardial infarction, thrombosis in device, vascular occlusion, . FABRAZYME dosage: 70 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5601560-5
CAPECITABINE problem was reported by a Physician from CANADA on Jan 14, 2008. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, iliac artery occlusion, vascular occlusion, vomiting, . CAPECITABINE dosage: 2150 MG GIVEN TWICE DAILY FOR FOURTEEN DAYS.. During the same period patient was treated with EPIRUBICIN, CARBOPLATIN, METOCLOPRAMIDE, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Cilostazol Side Effects Report #5567396-9
Consumer or non-health professional from GERMANY reported CILOSTAZOL problem on Dec 03, 2007. Female patient, 60 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, iliac artery occlusion, reocclusion, . CILOSTAZOL dosage: 50 MG/100 MG/200 MG ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Capecitabine Side Effects Report #5578064-1
CAPECITABINE problem was reported by a Physician from CANADA on Dec 18, 2007. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, iliac artery occlusion, vascular occlusion, vomiting, . CAPECITABINE dosage: 2150 MG GIVEN TWICE DAILY FOR FOURTEEN DAYS.. During the same period patient was treated with EPIRUBICIN, CARBOPLATIN, METOCLOPRAMIDE, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Doxil Side Effects Report #5302932-9
Health Professional from UNITED STATES reported DOXIL problem on Apr 17, 2007. Male patient, weighting 182.0 lb, was diagnosed with prostate cancer and was treated with DOXIL. After drug was administered, patient experienced the following problems/side effects: cholecystitis acute, iliac artery occlusion, peripheral ischaemia, sepsis syndrome, urogenital fistula, urosepsis, . DOXIL dosage: 58 MG DAY 1 Q 28 DAYS IV. During the same period patient was treated with TAXOTERE, ASPIRIN, IMODIUM, ATENOLOL, NORVASC, LISINOPRIL, POTASSIUM CHLORIDE, LASIX. Patient was hospitalized. Patient recovered.
Fosamax Side Effects Report #5565769-1
FOSAMAX problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, atrial fibrillation, iliac artery occlusion, osteomyelitis, osteonecrosis, . FOSAMAX dosage: unknown. Patient was hospitalized. Patient recovered.
Fosamax Side Effects Report #5567473-2
Health Professional from UNITED STATES reported FOSAMAX problem on Dec 17, 2007. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with osteoporosis and was treated with FOSAMAX. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, atrial fibrillation, iliac artery occlusion, osteomyelitis, osteonecrosis, . FOSAMAX dosage: unknown. Patient was hospitalized. Patient recovered.